Liver cancer (LC) is the third largest contributor to mortality related to malignancies worldwide. The study was directed toward exploring the effects of miR-223 on LC proliferation and apoptosis. Dual luciferase reporter assay (DLRA) was carried out to verify the direct relationship of TLR4 mRNA 3-UTR and miR-223-3p. HepG2 cells subsequently were transfected with miR-223 mimics. MTT assay and flow cytometric assay were carried out to evaluate proliferation and cell death, respectively. Toll-like receptor 4 (TLR4) transcription and translation were examined via qRT-PCR and western blotting, respectively. We observed that the miR-223 expression in LC tissues was inhibited, accompanied by reinforced TLR4 expression. Excessive miR-223 expression noticeably inhibited cell growth and promoted apoptosis in HepG2 and Bel-7402 HCC cell lines. Additionally, knockdown of TLR4 expression could suppress cell growth and promote apoptosis in HepG2 and Bel-7402 HCC cell lines. Moreover, TLR4 expression was suppressed via miR-223 transfection. T DLRA verified that miR-223 directly targeted TLR4. TLR4 over-expression canceled the effects of miR-223 on LC proliferation and apoptosis. Collectively, our findings suggest that miR-223 is an inhibitor of malignancy and participates in the inhibition of malignancy generation and reinforcement of LC cell death by targeting TLR4.